Novo Nordisk
NVO
#106
Rank
NZ$282.88 B
Marketcap
NZ$63.73
Share price
-0.73%
Change (1 day)
-46.34%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report